14.49 EUR
Free delivery accross Estonia to SmartPosti Itella parcel lockers for orders from 40 EUR.
Free courier delivery across Estonia for orders from 80 eur.
For the prophylaxis and supportive treatment of viral infections of the respiratory tract.
For use in adults and children from 1 year.
May be used during pregnancy and breast-feeding.
For more information please visit www.agovirax.com
Therapeutic indications
Agovirax is indicated for the prophylaxis and supportive treatment of viral infections of the respiratory tract.
Agovirax can shorten the duration of flu-like illnesses and alleviate the severity of cold symptoms. Agovirax can reduce new infections and resurgence of virus-related cold symptoms.
Agovirax can be used additionally for the preventive and sustainable moistening of the nasal mucosa and thus for the prophylaxis and supportive treatment of all complaints resulting from dry and irritated nasal mucosa.
Mode of action
Low humidity and air pollution can lead to a dry nasal mucous membrane. However, the nose is only able to fulfil its filtering function if the nasal mucous membrane is sufficiently moistened. Agovirax forms a moisturising protective film on the nasal mucous membrane. This liquid layer serves as a physical barrier against external influences. The sustained moistening can guard against common cold and flu-like illness caused by cold viruses.
The nose is the most common route of infection for viruses that trigger common cold and flu-like illness. Flu-like illnesses are caused by viruses such as rhinoviruses and coronaviruses for example. If viruses have penetrated into the nose, they can attach themselves to the mucous membrane and infect mucosal cells where they multiply and spread. This results in the typical symptoms of a cold, like a blocked or runny nose, sore throat and/or headache, cough, etc.
In the early stages of a disease you often cannot distinguish with certainty between a common cold and influenza. Influenza is a potentially serious disease; the definitive diagnosis requires a doctor.
Agovirax contains iota-carrageenan, a marine substance derived from red algae. Iota-carrageenan has a dual positive effect.
When should Agovirax not be used?
In case of known hypersensitivity to any of the ingredients.
Possible side effects of Agovirax
At present, no other side effects besides very rare cases of hypersensitivity are known. There are no known interactions.
Studies on interactions with other products were not performed.
Special precautions for safe use
Agovirax has a local action. Iota-carrageenan is not absorbed by the cells of the nasal mucosa.
Agovirax may be used during pregnancy and breast-feeding.
If the symptoms persist, you must consult a doctor.
For hygienic reasons and to avoid the transmission of pathogens, one spray bottle should always be used by one and the same person.
Keep out of the sight and reach of children!
Further information
Agovirax may be used for a longer period of time. There is no potential for addiction or risk of overdose.
Agovirax contains the natural substance iota-carrageenan.
Agovirax is a medical device and clinically tested.
Agovirax contains no analgesic, no preservative, no constituent of animal origin or greenhouse gas.
Agovirax is lactose- and gluten-free and can be used by diabetics and vegans.
Agovirax has no decongestant effect, contains no preservatives. A sterile filter guarantees the sterility of the solution even after repeated use.
Package size
20 ml bottle with spray pump; 1 puff = 0.14 ml of solution (142 puffs in total).
Storage instructions
Store between 5 °C and 30 °C.
Protect from light.
Manufactured by: Hälsa Pharma GmbH, Lübeck, Germany
Agovirax is a clear, colorless, viscous solution without odour. 1 ml of the solution contains 1.2 mg iota-carrageenan, 0.4 mg kappa-carrageenan, sodium chloride and purified water.
At first signs of a flu-like infection (e.g., throat pain, tingling or runny nose, etc.), one puff should be sprayed at least 3 times daily into each nostril. Treatment should be initiated as early as possible after the onset of the first cold symptoms and be continued until the symptoms have subsided. If fever develops or there is no improvement after 1 week of treatment, a physician should be consulted.
For moisturising dry nasal mucosa, spray few puffs into the nose several times a day depending on individual requirements.
